{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P22897",
      "entity_text" : "MMR",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:Interferon",
      "entity_text" : "IFN",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "IFN / imatinib induction treatment followed by a temporary IFN maintenance may enable a higher rate of treatment discontinuation in CML patients in at least MMR when stopping TKI.",
  "reading_complete" : "2020-08-04T10:01:13Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T09:57:39Z",
  "trigger" : "enable",
  "evidence" : [ "IFN/imatinib induction treatment followed by a temporary IFN maintenance may enable a higher rate of treatment discontinuation in CML patients in at least MMR" ],
  "pmc_id" : "5402174",
  "score" : 0
}